4//SEC Filing
GALLAHUE KIERAN 4
Accession 0001225208-24-002963
CIK 0001099800other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 5:52 PM ET
Size
11.6 KB
Accession
0001225208-24-002963
Insider Transaction Report
Form 4
Gallahue Kieran
Director
Transactions
- Exercise/Conversion
Common Stock
2024-02-23$36.86/sh+7,056$260,107→ 10,757 total - Gift
Common Stock
2024-02-23−7,056→ 3,701 total - Gift
Common Stock
2024-02-23+7,056→ 70,277 total(indirect: By Trust) - Exercise/Conversion
Director Stock Option (Right to Acquire)
2024-02-23−7,056→ 0 totalExercise: $36.86From: 2017-05-12Exp: 2024-05-11→ Common Stock (7,056 underlying) - Sale
Common Stock
2024-02-23$87.61/sh−3,058$267,911→ 67,219 total(indirect: By Trust)
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $87.5908 to $87.6210. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001308428
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 5:52 PM ET
- Size
- 11.6 KB